Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
This study has been completed.
Study NCT00073710 Information provided by Abbott
First Received on December 3, 2003. Last Updated on July 31, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Secondary Hyperparathyroidism
Chronic Kidney Disease
Additional conditions recognized in this trial
Hyperparathyroidism
Hyperparathyroidism, Secondary
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Endocrine System Diseases
Parathyroid Diseases
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
Zemplar
Calcijex
Additional drug interventions recognized in this trial
Calcitriol
More general drug interventions related to this trial
Bone Density Conservation Agents
Calcium Channel Agonists
Cardiovascular Agents
Growth Substances
Membrane Transport Modulators
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasoconstrictor Agents
Vitamins
Sponsors listed in this trial
Abbott
Back to top of Main Content
